C-reactive protein predicts response to infliximab in patients with chronic sarcoidosis.
Nadera Sweiss(University of Illinois Chicago), Robert P. Baughman(University of Cincinnati), Elliot S. Barnathan(Johnson & Johnson (United States)), Marc A. Judson(Cleveland Clinic), Kim Hung Lo
PubMed
July 1, 2010
Cited by 54
Related Papers
Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|1k
Practice Guidelines for Diseases Caused by Aspergillus
|Clinical Infectious Diseases|2000|797
ERS clinical practice guidelines on treatment of sarcoidosis
|European Respiratory Journal|2021|579
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
|PubMed|2014|505
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503